Revatio and Triamcinolone acetonide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Revatio (sildenafil citrate) and Triamcinolone acetonide (triamcinolone acetonide). Common drug interactions include malaise among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Revatio and Triamcinolone acetonide. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Revatio?

Revatio has active ingredients of sildenafil citrate. It is often used in pulmonary hypertension. eHealthMe is studying from 44,849 Revatio users. Check the latest studies of Revatio.

What is Triamcinolone acetonide?

Triamcinolone acetonide has active ingredients of triamcinolone acetonide. It is often used in eczema. eHealthMe is studying from 19,594 Triamcinolone acetonide users. Check the latest studies of Triamcinolone acetonide.



On Jul, 20, 2026

23 people who take Revatio and Triamcinolone acetonide together, and have interactions are studied.

Revatio and Triamcinolone acetonide drug interactions.

What are the common drug interactions of Revatio and Triamcinolone Acetonide, by gender? *:

female:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Oesophageal disorder (disease of oesophagus)
  3. Dyspnoea (difficult or laboured respiration)
  4. Cystitis (inflammation of the wall of the bladder)
  5. Epistaxis (bleed from the nose)
  6. Fatigue (feeling of tiredness)
  7. Hypocoagulable state (abnormality of blood coagulation that increases the risk of thrombosis)
  8. Infection
  9. Sinusitis (inflammation of sinus)
  10. Death

male:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Chronic kidney disease
  3. Death
  4. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  5. Drug ineffective
  6. Dyspnoea (difficult or laboured respiration)
  7. Eye swelling
  8. Hypoacusis (loss of hearing)
  9. Hypokalaemia (low potassium)
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the common drug interactions of Revatio and Triamcinolone Acetonide, by age (0-1 to 60+)? *:

0-1:

  1. Colostomy
  2. Cough
  3. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  4. Dyspnoea (difficult or laboured respiration)
  5. Eye swelling
  6. Hypoacusis (loss of hearing)
  7. Leukopenia (less number of white blood cells in blood)
  8. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  9. Procedural pain
  10. Pulmonary arterial pressure increased

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Blood pressure increased
  2. Infection
  3. Pain
  4. Pyrexia (fever)
  5. Chronic kidney disease
  6. Renal failure (kidney dysfunction)
  7. Death

60+:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Oesophageal disorder (disease of oesophagus)
  3. Weight increased
  4. Anaemia (lack of blood)
  5. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  6. Cardiac failure congestive
  7. Cardiac output decreased
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Drug ineffective
  10. Fall

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 11 people, 47.83%
  2. Lung Disorder (lung disease): 4 people, 17.39%
  3. Depression: 4 people, 17.39%
  4. Dyspnea (difficult or laboured breathing): 3 people, 13.04%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.04%
  6. Nausea (feeling of having an urge to vomit): 3 people, 13.04%
  7. Nausea And Vomiting: 3 people, 13.04%
  8. Pain: 3 people, 13.04%
  9. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 13.04%
  10. Pulmonary Thrombosis (scarring in the lungs): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Revatio and Triamcinolone acetonide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Revatio and Triamcinolone acetonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Revatio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Triamcinolone acetonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Revatio and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Triamcinolone acetonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on sildenafil citrate and triamcinolone acetonide (the active ingredients of Revatio and Triamcinolone acetonide, respectively), and Revatio and Triamcinolone acetonide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: